Option Care Health Inc is the provider of home and alternate-site infusion services... Show more
a provider of home and alternate site infusion services.
Industry HospitalNursingManagement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IXC | 58.04 | 0.20 | +0.35% |
| iShares Global Energy ETF (IXC) | |||
| DJUL | 51.34 | 0.08 | +0.16% |
| FT Vest U.S. Equity Deep Buffer ETF - July (DJUL) | |||
| EJAN | 37.12 | -0.09 | -0.24% |
| Innovator Emerging Markets Power Buffer ETF January (EJAN) | |||
| EART | 28.32 | -0.28 | -0.98% |
| Global X Rare Earth & Critical Materials ETF (EART) | |||
| BULG | 34.29 | -3.85 | -10.09% |
| Leverage Shares 2X Long BULL Daily ETF (BULG) | |||
A.I.dvisor tells us that OPCH and CHE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OPCH and CHE's prices will move in lockstep.
| Ticker / NAME | Correlation To OPCH | 1D Price Change % | ||
|---|---|---|---|---|
| OPCH | 100% | -1.71% | ||
| CHE - OPCH | 32% Poorly correlated | -0.49% | ||
| ADUS - OPCH | 31% Poorly correlated | -0.77% | ||
| FMS - OPCH | 30% Poorly correlated | -0.27% | ||
| UHS - OPCH | 27% Poorly correlated | -2.43% | ||
| CYH - OPCH | 26% Poorly correlated | -4.32% | ||
More | ||||
| Ticker / NAME | Correlation To OPCH | 1D Price Change % |
|---|---|---|
| OPCH | 100% | -1.71% |
| Hospital/Nursing Management industry (48 stocks) | 2% Poorly correlated | +1.38% |
OPCH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 26 of 35 cases where OPCH's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 74%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +4.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where OPCH advanced for three days, in 177 of 295 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
The Aroon Indicator entered an Uptrend today. In 155 of 217 cases where OPCH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.
The Momentum Indicator moved below the 0 level on September 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OPCH as a result. In 64 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 65%.
The Moving Average Convergence Divergence Histogram (MACD) for OPCH turned negative on September 21, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 32 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 68%.
OPCH moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OPCH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.
The Tickeron SMR rating for this company is 54 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating fairly steady price growth. OPCH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 64 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.727) is normal, around the industry mean (208.231). P/E Ratio (17.379) is within average values for comparable stocks, (175.102). Projected Growth (PEG Ratio) (1.103) is also within normal values, averaging (2.490). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (0.682) is also within normal values, averaging (2.688).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OPCH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.